Results 11 to 20 of about 18,308 (133)
Risk factors for low‐risk prostate cancer: A retrospective cohort study within the FinRSPC trial
What's New? Overdiagnosis of low‐risk prostate cancer remains an important downside of prostate‐specific antigen‐based screening. This retrospective cohort study of 80,144 men with a median follow‐up of 18.0 years shows that risk factors for low‐risk prostate cancer differ significantly from those for high‐risk prostate cancer.
Uzoamaka E. Okwor+6 more
wiley +1 more source
What's New? High physical activity levels have been linked to a lower cancer recurrence risk in patients with solid tumors, but evidence is lacking for non‐muscle invasive bladder cancer. This prospective observational cohort study found no clear associations between prediagnosis or postdiagnosis physical activity levels and the risk of recurrence or ...
Ivy Beeren+8 more
wiley +1 more source
TMB‐High, MSI‐High Castration‐Resistant Prostate Cancer Treated With Pembrolizumab
ABSTRACT Introduction The use of pembrolizumab in patients with microsatellite instability‐high (MSI‐high) and tumor mutation burden‐high (TMB‐high) prostate cancer in Japan is not widely reported. Here, we report the case of a patient with MSI‐high and TMB‐high prostate cancer who responded well to pembrolizumab after multiple systemic treatments ...
Satoshi Muraoka+8 more
wiley +1 more source
ABSTRACT Introduction There are no previous reports of solitary renal metastases from urothelial carcinoma with trophoblastic differentiation, a rare bladder cancer subtype that is pathologically hCGβ positive. Case Presentation A 77‐year‐old male with urothelial carcinoma with trophoblastic differentiation underwent robot‐assisted radical cystectomy ...
Seiichiro Honda+10 more
wiley +1 more source
Systemic Transthyretin Amyloidosis Incidentally Diagnosed With Prostate Biopsy: A Case Report
ABSTRACT Introduction The diagnosis of systemic transthyretin amyloidosis based on prostate biopsy is very rare, and we report this case with a literature review. Case Presentation A 73‐year‐old male patient was referred to our department due to an increased serum prostate‐specific antigen level at 10.4 ng/mL while receiving benign prostatic ...
Michihide Nakamura+14 more
wiley +1 more source
Interstitial Cystitis/Bladder Pain Syndrome in Men
ABSTRACT Aims In April 2025, the Wake Forest Institute for Regenerative Medicine hosted a Global Consensus meeting on interstitial cystitis/bladder pain syndrome (IC/BPS) in Winston‐Salem, NC. The goal of this meeting was to establish attainable targets in phenotyping, diagnosis, and biomarkers for IC/BPS.
Madeline Snipes+5 more
wiley +1 more source
Senescent BPH epithelial cells secrete CXCL13 to recruit CD4+ T cells via CXCR5. Cytotoxic CD4+ T cells eliminate senescent cells through MHC‐II–dependent recognition. Tregs suppress, while B cells show minimal effect. This immune axis modulates senescent cell clearance and may influence BPH progression.
Zheng Li+16 more
wiley +1 more source
Recommendation on the use of protective eyewear in endourological laser procedures
Objectives This work examines the current evidence available regarding the risks of eye injury in endourology laser environments with the aim of providing a consensus recommendation on the appropriate use of protective eyewear. Methods A working group was set up consisting of urological surgeons and laser protection advisors.
Tom Lister+7 more
wiley +1 more source
A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer
Objectives To evaluate the effect of metformin on non‐muscle‐invasive bladder cancer (NMIBC) marker lesions. Patients and methods A phase II, open‐label, multicentre, marker lesion trial using oral metformin in patients with primary or recurrent, multiple, low‐grade Ta‐T1 NMIBC was conducted. After transurethral resection for histological confirmation,
Jons W. van Hattum+12 more
wiley +1 more source
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study
Objective To report real‐world rates of non‐muscle‐invasive bladder cancer (NMIBC) recurrence and progression within a European multicentre cohort with detailed information on intravesical instillation courses, as contemporary data on oncological outcomes in NMIBC are limited.
Mattia Longoni+28 more
wiley +1 more source